Human DAO ELISA Kit (Chemiluminescence)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-50098
Key Product Details
Sample Type & Volume Required Per Well
Serum, plasma and other biological fluids (100 uL)
Sensitivity
0.47 ng/mL
Assay Range
0.78 - 50 ng/mL
Product Specifications
Assay Type
Sandwich ELISA
Kit Type
ELISA Kit (Chemiluminescence)
Reactivity
Human
Specificity
This kit recognizes Human DAO in samples. No significant cross-reactivity or interference between Human DAO and analogues was observed
Description
Assay Length: 3 h 30 min
Precision
Intra-Assay Precision (Precision within an assay) CV% < 10
Inter-Assay Precision (Precision between assays) CV% < 10
Recovery for Human DAO ELISA Kit (Chemiluminescence)
Recovery
80 - 120%
Linearity
Scientific Data Images for Human DAO ELISA Kit (Chemiluminescence)
ELISA: Human DAO ELISA Kit (Chemiluminescence) [NBP3-50098]
Standard Curve Reference.Kit Contents for Human DAO ELISA Kit (Chemiluminescence)
- Biotinylated Detection Ab Diluent
- Certificate of Analysis
- Concentrated Biotinylated Detection Ab (100x)
- Concentrated HRP Conjugate(100x)
- Concentrated Wash Buffer (25x)
- HRP Conjugate Diluent
- Micro CLIA Plate (Dismountable)
- Plate Sealer
- Product Description
- Reference Standard
- Reference Standard & Sample Diluent
- Substrate Reagent A
- Substrate Reagent B
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: D-Amino Acid Oxidase
Long Name
D-Amino Acid Oxidase
Alternate Names
DAAO, DAMOX, DAO, OXDA
Gene Symbol
DAO
Additional D-Amino Acid Oxidase Products
Product Documents for Human DAO ELISA Kit (Chemiluminescence)
Product Specific Notices for Human DAO ELISA Kit (Chemiluminescence)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...